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Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of lung cancer is problematic due
to the lack of a marker with high diagnosis sensitivity and speciﬁcity. To determine the diﬀerently expressed proteins in the
serum of lung cancer and ﬁgure out the function of the proteins, two-dimensional electrophoresis (2DE) and matrix-assisted
laser desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF-MS) were used to screen the serum proteins of lung
cancermodelinducedby3-methylcholanthrene(MCA).Fromoptimized2DEimage,455spotsinthenormalseraand716spotsin
the lung cancers sera were detected. Among them, 141 protein spots were diﬀerentially expressed when comparing the serum from
normal rat and serum from lung cancer model, including 82 overexpressed proteins and 59 underexpressed proteins. Changes of
haptoglobin, transthyretin, and TNF superfamily member 8 (TNFRS8) were conﬁrmed in sera from lung cancer by MALDI-TOF-
MS.Proteomicstechnologyleadstoidentifychangesofhaptoglobin,transthyretin,andTNFRS8inserumofratlungcancermodel
and represents a powerful tool in searching for candidate proteins as biomarkers.
Copyright © 2009 Minhua Li et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Nowadays, lung cancer is one of the most common malig-
nant tumors. Statistics demonstrate that, in the past 20 years,
with the development of industry and aggravation of air pol-
lution, the morbidity rate and mortality rate of lung cancer
areincreasingmostquicklyinallmalignanttumorsinChina.
In cities, the mortality of lung cancer is 27.5/1000000,
accounting for 22.4/100 of all death in malignant tumors [1].
Theﬁve-yearsurvivalrateis14/100inAmerica,lessinChina.
Besides the reasons of environment pollution, smoking,
heredity, lack of early diagnostic tools is also the important
factor which contributes to that bad situation. In the recent
years, with the development of biology and imageology, for
example, spiral CT, cytological examination of sputum and
endoscopyofbronchus,andsoon,positiverateofearlydiag-
nosisisincreasingbuttherearerelatedlimitationsinallkinds
of methods. Maybe they lead to missed diagnosis in early
lung cancer. The sensitivity of ﬁne needle aspiration biopsy
(FNAB) in diagnosis of malignant nodes is 70/100–100/100
[2], but it may destroy some normal tissues and bring
about some complications, for instance, pneumatothorax
and hemoptysis. Blood plasma is the most easily controlled
and acquired specimen. So making use of serum sample
to detect special markers is the most perfect method in
diagnosis of clinical lung cancer. The reasons why we choose
the blood plasma as the pathﬁnder of proteome research
are as follows. (i) Serum proteome is the most complicated
proteome, including inferior proteome in diﬀerent tissues.
(ii) It is easy to obtain enough serum proteins as research
sample and it is easy to be standardized. (iii) There is a large
range of dynamic state in property of serum proteins. (iv)
There is no strict linear relationship between the expression
levels of the mRNAs and proteins. The modiﬁcation after
translation, such as glycosylation and phosphorylation, is
more and more popular, so it is necessary to globally analyze
the secreted proteins expressed by cells or tissues.
In the research of neoplastic serum proteomics, the
related proteomics technology is principally used to fathom
thechangeofserumproteinsinthecourseofformingtumor,
to screen and discover the tumor markers and potential
drug targets which could be used for classiﬁcation, early
diagnosis,therapy,andinterventionofthetumor.Nowadays,
two technical modes are often applied in the research of2 Journal of Biomedicine and Biotechnology
serum proteomics: (i) surface-enhanced laser desorption
and ionization take-of-ﬂight mass spectrometry (SELDI-
TOF-MS), (ii) matrix assisted laser desorption/ionization
time-of-ﬂight mass spectrometry (MALDI-TOF-MS). The
new generation of MALDI-TOF-MS could quickly, exactly
identify polypeptides and proteins with high sensitivity and
high throughput. There are many advantages: (i) Small
needed quantity (fmol), (ii) short time of analysis (3–5
minutes), (iii) high accuracy of quality (1/10000), (iv) the
immunity to the eﬀect of N-terminal close, (v) making use
of situ-enzymolysis-technology could directly identify the
protein spots which are cut from gels. So it reduces the
loss of specimen, (vi) it could identify a single protein in
protein mixture and directly identify the modiﬁcation after
translation [3, 4]. So it develops quickly and becomes the
preferred way of analyzing polypeptides and proteins in
laboratory. In our research, we made the rats our lung cancer
model which was induced with MCA, used the method
of 2DE combined with MALDI-TOF-MS, made compared
serum proteomics research in lung cancer, analyzed the
changes of serum proteins before and after the formation of
lung cancer in same body, identiﬁed serum proteins which
related to lung cancer for oﬀering serum proteomic evidence
to probe the pathogenesis of lung cancer as well as providing
new style to probe hematological diagnostic method of lung
cancer.
2.Materials
2.1. Animals. 20 Wistar rats (10 male, 10 female) were
purchasedfromExperimentalZoologyDepartmentatTongji
Medical College in Huazhong Technology University. They
ranged in weight from 180g to 200g.
2.2. Reagents. 3-methylcholanthrene (MCA) was the pro-
duct of Sigma (Sigma-Aldrich, Inc, Saint Louis, Missouri,
USA), immobilized pH gradient Dry strip was pur-
chased from Amersham Pharmacia Biotech Company,
sodium dodecyl sulfate (SDS), dithiothreitol (DTT),
tris(hydroxymethyl) aminomethane (Tris), bromophenol
blue (BPB), ammonium persulfate (APS), Glycine, Acry-
lamide, Methylene bisacrylamide (BIS), tetramethylethyl-
enediamine (TEMED), IPG-Buﬀer, Drystrip cover ﬂuid,
Agarose, Carbamide, protein-markers were purchased
from A-Pharmacia Co., coomassie brilliant blue R-250,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulf-
onate (CHAPS) were purchased from Sigma Co., Glacial
Acetic Acid, methanol, glycerol, paraform, alcohol were
national analytical pure, sequencing-grade modiﬁed trypsin
was purchased from American Roche Co., α-cyano-4-
hydroxycinnamic acid (CCA) (Sigma Co.), acetonitrile
(ACN) (Fisher chromatographic pure), Tri-Fluoro-acetic-
Acid (TFA) (Sigma Co.). Water was Milli-Q ultrapure water.
2.3. Major Equipments. IPGphor isoelectric focusing elec-
trophoretic apparatus was purchased from Swedish Amer-
sham pharmacia Biotech Co., PROTEANXI Cell vertical
electrophoretic apparatus was purchased from BIO-RAD
Co., Image Scanner was purchased from Swedish Amersham
pharmacia Biotech Co., CentriVap Centrifugal Concentra-
tors and Cold Traps were purchased from LABCONCO Co.,
SpotcutterapparatuswaspurchasedfromBIO-RADCo.,and
AutoﬂexMALDI-TOF-MSmassspectrometryapparatuswas
purchased from Germany BRUKER Co.
2.4. Ancillary Software. Image Master IDE software and
MASCOT software are found in http://www.matrixscience
.com/search form select.html.
3. Methods
3.1. Induction of Lung Cancer Model. T h er a t sw e r ek e p t
in cozy (15–25
◦C), quiet and avoided of highlight for 58
hours before making the experiment. The rats were kept
for 14 days after the whole blood was collected by heart
puncture. Then we made the model of lung cancer induced
with MCA in iodized oil by intrabronchial installation [5,
6] with minor modiﬁcations. The details were as follow:
Iodized oil 0.1mL containing MCA 10mg was dissolved at
76–78
◦C for 24 hours. As the basal anesthesia, Ketamine
hydrochloride 0.12mL was injected into the muscle of right
thigh (0.6mL/kg), at the same time, penicillin 20000u and
phytomycin 50mg per rat were injected into the muscle of
left thigh once a day for a week for infection prevention.
After about 2-3 minutes, early drugged state was showed up,
and then the rats were anaesthetized with diethylether for
relaxing the muscle of laryngeal. The anaesthetized rats were
put on a consple with 45
◦C inclined plane and the upper
jaw incisor teeth were ﬁxed by a retention suture on superior
extremity of table top. The throat was exposed with gripping
tweezers and bended tongue spatula with elastic metals. In
a frontal mirror, at the moment of inspiration, the injection
needle with blunt end in 1mL syringe was inserted in glottis
until reached the crotch of trachea, then turned left bottom
tolobarbronchiininferiorlobeofleftlung,andtheniodized
oil 0.1mL with MCA 10mg was injected. Take pictures with
DSA after installation for a day to ﬁnd the location of iodized
oil with MCA. Sacriﬁced the animals after installation for
180 days dissected the rats systematically and took the tissues
where pathological changes were obvious and all organs,
metastasis, lymph nodes with suspected of invasion, ﬁxed
themwithparaform,embededthemwithparaﬃnwax,sliced
them, and stained with HE.
3.2. Serum Sample Preparations. T h er a t sw e r er a i s e dw i t h
skins of hind neck in order that the limbs could downward
sagging after they were anesthetized with diethylether. The
injector that contains heparin was used to pump blood
(1–3mL) on the left chest wall where the heart beats
most powerfully (1.5–2cm higher than the lower margin of
ensiform cartilage). The blood was kept in centrifuge tube
for30minutesatroomtemperature,centrifugedat2000rpm
for 15 minutes. The plasma was taken out and aliquoted into
sterile EP tubes, stored at −70
◦C until used.
Ten rats with lung cancer were chosen by pathological
diagnosis. 50uL plasma was taken out, respectively, beforeJournal of Biomedicine and Biotechnology 3
and after the formation of lung cancer, then combined and
quantiﬁed with Bradford method, followed by taking 1mg
protein used for isoelectric focusing.
3.3. 2-DE. All measurements were performed as described
previously [7] with minor modiﬁcation.
3.3.1. IEF. In the ﬁrst dimension, proteins were separated by
IEF with IPG strip (pH3–10, nonlinear gradient and pH4–
7, linear gradient, both 180mm × 3mm× 0.5mm). Of the
total proteins, 1mg was dissolved in lysis buﬀer (8M urea,
0.02 CHAPS, 0.02M DTT, 0.05 IPG buﬀer) to obtain a total
volume of 350uL per strip. Focused IPG were rehydrated at
30v for 6 hours, at 500v for 1 hour, at 1000v for 1 hour, and
at 8000v for 10 hours.
3.3.2. Balance. After IEF, IPG strips were washed with
Milli-Q water and then incubated in equilibration buﬀer
(30% glucerin, 6M urea, 2% SDS, 50Mm Tris-HcL pH
8.8, trace bromophenol blue) containing 20mM DTT on
rocking bed for 15 minutes, followed by 15 minutes incu-
bation in the same equilibration buﬀer containing 100mM-
Iodoacetamide on rocking bed.
3.3.3. SDS-PAGE. T h es e c o n dv e r t i c a lS D S - P A G Ew a sp e r -
formed in PROTEANXI CELL. Equilibrated IPG strips were
placed on top of a 13% homogeneous SDS-polyacrylamide
gel. A scrap of ﬁlter paper was immersed in 10uL protein
marker and put on top of one side of the gel. The edge
was sealed with 0.5% agarose. 13% SDS-PAGE gels 75mL
contained 30% ACR/0.8% BIS 33.5mL, 4 × Tris-HCL
19.5mL pH 8.8, Milli-Q water 24.5mL, 10% APS 0.25mL,
TEMED 0.05mL. Gels were run in parallel at constant power
(40mA for 40 minutes, 60mA for 5 hours) in running buﬀer
until BPB reached the bottom line of each gel.
3.3.4. Protein Staining. The gels were put into 0.1%
coomassie brilliant blue solution (methanol 484mL, glacial
acetic acid 92mL, Milli-Q water 454mL, Coomasie brilliant
blue R-250 1g) and stained on rocking bed for 3 hours.
After pouring out the coomassie brilliant blue solution, we
decolored them in depigmenting agent solution (methanol
50mL, glacial acetic acid 75mL, Milli-Q water 875mL) for
24 hours until the background of gel pieces became clear and
transparent.
3.3.5. Image Analysis. G e li m a g e sw e r es c a n n e dw i t hI m a g e
Scanner. Spots detection, quantiﬁcation, matching and com-
parison of 2DE protein pattern weredone with ImageMaster
IDE software. In the protein matching, serum protein gel
maps of normal controls were regarded as referenced gel,
artiﬁcial matched spots were built up, and the analysis of
diﬀerent expression was performed by applied software.
The abundance of each protein spot was estimated by
the percentage volume. The individual spot volumes were
normalized by dividing their intensity values by the total
intensity values of all the spots present in the gel and
expressed as % vol. If the ratio of relative content in diﬀerent
group was more than 2 or less than 0.5, we could assess there
were diﬀerences.
3.4.ProteinIdentiﬁcationbyMALDI-TOF-MS. Itwascarried
out by the procedure described in detail previously [7]w i t h
minor modiﬁcation.
3.4.1. In-Gel Digestion. We chose 13 diﬀerently expressed
protein spots with clear margin and high abundance protein.
Of all the spots, 7 protein spots were overexpressed, 4
protein spots were underexpressed, and 2 protein spots were
new in the plasmas of lung cancer. The chosen protein
spots in 2DE maps were excised with spot-cutter apparatus
and transferred into 1.5mL EP tube, followed by washing
them thrice with 1mL water for 10 minutes. Gel pieces
were discolored in 50–100uL solution (50% acetonitrile,
25mmol/L ammonium bicarbonate) for 20 minutes with
constant oscillation, followed by discarding the solution,
repeated 1-2 times until blue color disappeared, dried them
in vacuum centrifugal dryer for 30 minutes. Then 5–10uL
of 0.01ug/uL trypsin diluted in 25mmol/L ammonium
bicarbonate was added to each sample tube for digesting
the proteins and kept the tubes in freezer at 4◦C for 20–30
minutes. After all digestion solution was ingested, 5–10uL of
25mmol/Lammoniumbicarbonatewasaddedtoit.Storedit
at 37
◦C for 15 hours. The digested polypeptides were eluted
twice with 5% TFA 50–100uL at 40
◦C for 1 hour and 2.5%
TFA, 50% ACN 50–100uL at 30
◦C for 1 hour, supernatants
were collected, combined, vacuum-dried by centrifugation
until used for mass spectrographic analysis.
3.4.2. Preparation of Peptide Mass Fingerprinting. 5uL of
0.5% TFA was added to dried sample tubes for dissolving
the peptides mixture. The sample and ground substances
(CCA added to 30% ACN or 10% aceton to obtain saturated
solution) were combined with 1:1 volume and spotted onto
the target plate, then air-dried.
3.4.3. The Detection of Peptide Mass Fingerprinting. Peptide
mass ﬁngerprinting spectrum was evaluated with a reﬂector
positive ion model in following setting: accelerating voltage,
20KV; reﬂected voltage, 1.12KV; nitrogen laser wavelength,
337nm; pulse width, 3 nanoseconds; delayed extraction
time, 100 nanoseconds; the degree of vacuum, 4×10
−7 Torr;
each spectrum was obtained by accumulating 50 laser
shots and averaging them. A matrix peak and a trypsin
autodigestionfragmentpeakservedasaninternalcalibration
standard.
3.4.4. MALDI-TOF-MS Analysis. It was performed to ana-
lyze the peptides. The peptide mass ﬁngerprinting of each
protein was searched from NCBInr database using Mascot
software. The functions of the identiﬁed protein were
searched by NCBI protein databanks. The conditions of
searchingareasfollows(i)Thepeptidesmasswerecontrolled
between 800Da and 4000Da. (ii) The sphere of error in
apparent pI and apparent Mr was +0.5pH and ±20%. (iii)
The largest error in molecular weight of peptide fragment4 Journal of Biomedicine and Biotechnology
Figure 1: The lung cancer specimen induced by MCA, showing
that the carcinoma cells formed nests in which the red horny pearl
wasobvious;carcinomacell nucleus wereverybigandvacuous,and
nucleoli were big and localized to the edge. HE × 200.
was controlled in the range of −0.3Da to +0.3Da. (iv) The
trypsin was chosen as the enzyme and the incomplete choice
of enzymolysis fragment was 1 or 2. (v) Mattus was chosen
as species resource. (vi) The peptide ions were [M+H]
+ and
monoisotopie.(vii)Thenumberofsmallestmatchedpeptide
fragment was 4. (viii) There were not limitations in the ﬁxed
modiﬁcation. The variable modiﬁcation was oxidation.
4. Results
Lung cancer models were made successfully after installing
MCA in iodized oil. It was demonstrated that iodized oil
was present in the inferior part of left pulmonary lobes by
scissors shadow with X-ray. Only in ten rats of 18 rats (two
rats died naturally in 20 rats), tubercles in bottom left of
pulmonarylobeswereobservedinnakedeye.Bypathological
examination, it was proved that they were squamous cell
carcinomas. The rate of induced-cancer was 55%. After
HE staining, by light microscope, we could observe that
carcinoma nests were diﬀerent in size and shape, the horny
pearl was obvious, cell nucleus were very big, part of them
were vacuous, the chromatins in cell nucleus were rough,
there were many karyokinesis, and nucleoli were big and
localized to the edge (Figure 1).
The good reproducible results were acquired using the
optimized 2DE technique. The electrophoresis of plasma
in 10 animal models was performed before and after
forming lung cancer, respectively. The protein spots were
separated better using pH4–7 IPGIEF (Figure 2(b)) than
pH3–10 IPGIEF (Figure 2(a)). The distribution patterns of
all proteins were similar. The protein spots in the range of
pI4–6 and Mr10–65kD were distributed most intensively.
When making an analysis of 2DE patterns which were
separated with pH4–7 IPG strip (Figure 3), we found that
455 spots on the normal plasmas 2DE patterns and 716
spotsonthelungcancerplasmas2DEpatternsweredetected.
When we matched the lung cancer plasmas 2DE patterns
with the normal plasmas 2DE patterns, it was demonstrated
that the number of matched protein spots was 295 and
matched rate was 50.38%.
141 protein spots were diﬀerently expressed signiﬁcantly
in plasmas 2DE patterns, 82 spots overexpressed in the
lung cancer and 59 spots overexpressed in normal controls.
We chose 13 diﬀerently expressed proteins spots with clear
margin and high quantity of proteins for MALDI-TOF-
MS analysis. Of all the protein spots, 7 protein spots were
o v e r e x p r e s s e d( n u m b e r s1 ,2 ,3 ,4 ,7 ,8 ,9 ) ,4p r o t e i ns p o t s
were underexpressed (numbers 10, 11, 12, 13), 2 protein
spots were new in the plasmas of lung cancer (numbers 5,
6) (Figures 4 and 5).
The peptide mass ﬁngerprinting maps were obtained
successfully by analysis of MALDI-TOF-MS after digesting
the chosen protein spots. Finally, 3 proteins were identiﬁed
through the NCBInr database search by Mascot software in
chosen 13 protein spots.
The3proteinswereheptoglobin(overexpressedprotein),
transthyretin (underexpressed protein), and tumor necrosis
factor receptor superfamily member 8 (new protein). The
ﬁgures were the mass spectrum of identiﬁed proteins spots
and detailed results of database retrieval (Figures 6, 7, 8, 9,
10,a n d11).
5. Discussion
MCA is an indirect chemical carcinogen, which belongs
to polycyclic aromatic hydrocarbon with 3, 4-benzpyrene,
and is responsible to air pollution. Its major eﬀect is to
make epithelium mucosae cell of bronchiole, respiratory
bronchiole squamous metaplasia and gradually progress to
squamous carcinoma cell. We had proved that there were a
series of changes of genetic materials and related genes in the
process of variation from normal bronchi epithelium to lung
squamouscarcinomacellbyimmunohistochemistrystaining
and molecular pathology [8, 9]. For example, the diﬀerent
positiveexpressionrateofP53proteinwas69.57%inratlung
cancer tissue. The positive expression rate of proliferative cell
nuclear antigen (PCNA) took up 20% in normal bronchi
epithelium tissue, and it advanced to 82.61% in inﬁltrating
lung cancer tissue. In addition, the number of strong positive
expressed cells was increasing obviously, even all carcinoma
nestswerepositiveexpressed,ithintedthechangesofactivity
of cell proliferation during the formation of lung cancer.
Thus making use of the model of rat lung cancer to carry
out serum proteome research was eﬀective and feasible.
Haptoglobin, one of acute phase proteins, is an acid
glycoprotein, which belongs to α2-globulin and extensively
exists in human plasmas and other body ﬂuid. Most of Hp is
synthesized in liver. In addition, Hp mRNA is also expressed
in human endometriotic lesions, intestinal epithelium and
mouse liver, lung, adipose tissue cell, skin [10]. Friedrichs
et al. [11] found that Hp mRNA was detected in some
special cells of adernal gland, submandibular gland, ovary,
ureter. Mi-Kyung et al. [12] further proved that Hp was
considered as a secretory protein, however, Hp synthesized
in THP-1 monocytic cells was largely retained within cells.Journal of Biomedicine and Biotechnology 5
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Figure 2: 2DE patterns after lung cancer formation. They were acquired by separating plasma of rats with lung cancer using pH3–10 (a) and
pH4–7 (b) IPG strips, showing there were many protein spots and the number of protein spots in (a) was more than that in (b) obviously.
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Figure 3: Analysis of 2DE protein matching after the formation of
lung cancer (pH 4–7). The green spots were the matched protein
spotsandtheredspotsweretheunmatched,thenumberofmatched
proteins was 295.
And Hp was degraded mainly in liver as well. The content
of Hp in plasmas often greatly increases in pathologic
state, for example, carcinoma, inﬂammation, infection,
myocarditis, and so on. The extent of severity correlates
with prognosis. The expression of Hp is accommodated by
lipopolysaccharide,cytokine,hormone[10].Themainfactor
stimulatesthecompositionofHpisIL-6.Ontheconditionof
inﬂammation, injury,IL-1,TNFaresecretedbymacrophage,
leading to the increase of IL-6, resulting in the composition
of Hp. In addition, D’Armiento [13] proved that Lps also
could stimulate the expression of Hp mRNA. Mi-Kyung
et al. [12] proved protein kinase-c-delta could stimulate
haptoglobin secretion as well. By forming the high-aﬃnity
complexes, Hp could bind free hemoglobin (Hb). In turn,
these Hp-Hb complexes could bind to the CD163 scavenger
receptor on macrophages with high speciﬁcity, leading to
endocytosis and subsequent intracellular degradation. So
Hp-Hb complex formation is considered to lessen the loss
of free Hb through glomerular ﬁltration and it is helpful for
supporting the recycling of iron. Moreover, because free Hb
is a source of iron, which may otherwise enhance bacterial
growth and virulence, so it is important that Hb released
from erythrocytes could be cleared promptly. Finally, free
Hb could release heme and iron which may participate in
generating reactive oxygen species (Fenton reaction) and
promote the injury of tissue as well. In a word, Hp works
indirectly as a bacteriostatic agent and an antioxidant in
the way of facilitating the immediate clearance of free Hb
by macrophages [14]. Haptoglobin polymorphism correlates
to the prevalence and clinical evolution of many inﬂamma-
tory diseases, for example, infections, atherosclerosis, and
autoimmune disorders [10] and that leads to the generation
of two distinct alleles, Hp2-1, Hp1-1, and Hp2-2. Hp2-2 has
beenreportedtobeassociatedwiththeriskofatherosclerosis
and coronary heart disease. Vormittag et al. [15] proved that
Hp2-2 was a potentially new risk factor for spontaneous
venousthromboembolismaswell.Therearemanyresearches
about Hp correlate with injury, inﬂammation, metabolic
disease [16–18]. More and more documents report that the
level of Hp in plasmas goes up in many malignant tumors,
such as ovarian cancer [19], breast cancer [20], renal cell
cancer [21], colon carcinoma [22], acute leukemia [23], and6 Journal of Biomedicine and Biotechnology
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Figure 4: Analysis of diﬀerent expressed spots after and before lung
cancer formation (a), ((a1), (a2), (a3)) Serum electropherogram of
lung cancer; (b), ((b1), (b2), (b3)) Serum electropherogram before
lung cancer formation (correspond to (a)). The diﬀerent expression
of13proteinspotswasobvious.Theredsignedspotswerethehigh-
expressed protein spots and the blue signed spots were the low-
expressed protein spots.
lung cancer [24]. Our research results were consistent with
them. In our research, we found Hp greatly increased in
lung cancer (the content of protein adds up to 8.328 times).
Though maybe it does not belong to speciﬁc protein in
lung cancer, owning to greatly increase level of Hp in the
activestageofcarcinomaandhighsensitivityofimmunology
method, it could become an important check index for
lung cancer diagnosis and monitoring and improve the
sensitivity and speciﬁcity of early diagnosis in lung cancer
when combining with other diagnostic indexes.
TTR also named preambumin and it is a tetrameric
protein of about 55kDa. The most of it is produced in liver
and choroid plexus of brain. As for its function, TTR could
transport the thyroid hormone T (4) and retinol through
binding to the retinol binding protein. In addition, TTR
has been established as a cryptic protease able to cleave
ApoA-I in vitro. Some scholars have reported that TTR
is involved in preventing A-Beta ﬁbrillization by inhibiting
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Figure 6: Peptide mass ﬁngerprinting map of protein spot 8.
and disrupting A-Beta ﬁbrils, with consequent abrogation of
toxicity [25]. TTR also plays an important role in nervous
system physiology [26]. Costa et al. [25] further conﬁrmed
that as a protective mechanism in Alzheimer’s disease (AD),
TTR could serve as a protective molecule in this disease
and prompted A-Beta proteolysis. It may be proved that
TTR is a useful therapeutic agent in preventing or retarding
the formation of cerebral amyloid plaque implicated in AD
pathology. In the past, someone conﬁrmed that in familialJournal of Biomedicine and Biotechnology 7
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Figure 7: Mascot search results of protein spot 8 are Haptoglobin.
Mowse Score was 89 (>58, P<. 05). When the ﬁgure was at the
margin of shadow, Mowse Score was 58 and P = .05. If the score
was more than 58, P<. 05.
amyloidotic polyneuropathy (FAP) which was associated
with the abnormal extracellular tissue deposition of mutant
transthyretin (TTR), inﬂammatory and apoptotic pathways
both are triggered in the presymptomatic stages of the
disease on the condition that nonﬁbrillar TTR deposits are
present [27]. TTR Arg-83 may be just the new pathologic
mutation in vitreous amyloidosis [28]. Meistermann et al.
[29] also reported that transthyretin could serve as a
biomarker for gentamicin-induced nephrotoxicity in rat.
TTR tetramer makes up a component in normal beta-cell
function. Conversion of TTR tetramer to monomer may
relate to the development of beta-cell failure/destruction
in type 1 diabetes [30]. In addition, TTR was upregulated
in T2DM [31]. So we could see that TTR expression was
associated with diabetes. At the same time, Bai et al. [32]
gussed that the concentration of TTR maybe relates to the
level of blood pressure, however, the concrete mechanism
is still unclear. Some researches about protein nutrition
indicated that TTR was a responsive nutrition index. The
content of TTR quickly decreased when the proteins were
insuﬃcient and increased obviously when the amount of
proteins gone up. Therefore, TTR was often used as an index
of evaluating nutritional state, especially the nutrition and
immunity state after operation [33, 34]. So far, reports about
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Figure 8: Peptide mass ﬁngerprinting map of protein spot 11.
TTR relate to tumors mainly concentrate on liver cancer,
ovariancancer,leukemia.Guetal.[35]ﬁrstreportedthatthe
gene of TTR had close correlation to liver cancer, they found
that the gene of TTR was expressed most highly in normal
liver. The level of its mRNA greatly went down in liver cancer
which the parenchyma was destroyed little. TTR was also
considered as potential serum marker in early ovarian cancer
[35–38]. In children with leukemia, the content of TTR and
RBP in plasmas was greatly less than that in normal children.
Thatdiﬀerencealsoexistedindiﬀerentrace,themelanoderm
children were much less, and the lower level related to
bad prognosis [39]. Some scholars [24] reported that TTR
was overexpressed in blood serum in lung squamous cell
carcinoma compared with normal lung. Our research also
demonstrated that the content of TTR in plasmas greatly
declined in the formation of lung cancer, it was consistent
with their results. The amount of proteins in normal ones
was 14 times bigger than that in lung cancer. So we could
consider that the function and mechanism of decrease need
further investigating.
TNFRS8 also named CD30, because Ki-1 monoclonal
antibody was used in identifying it, therefore it named
Ki-1 as well. As a marker of activation of T and B
lymphocytes, CD30 is a 120kDa surface phosphorylated
glycoprotein [40] and it is predominantly overexpressed by
the tumor cells (Hodgkin’s and Reed-Sternberg cells) of
classical Hodgkin’s lymphoma (cHL) and those of anaplastic
large cell lymphoma (ALCL) in classical Hodgkin lymphoma
[41]. It is well known that CD30 expression is not unique to
Hodgkin lymphoma and Anaplastic Large Cell Lymphoma
(ALCL) because of its expression in mediastinal large B cell
lymphoma, a subset of nodal diﬀuse large cell lymphoma,
large cells in follicular lymphoma, nodal and cutaneous
diﬀuse large B cell lymphoma, peripheral T cell lymphoma,
embryonal carcinoma, and other nonlymphoid cells and
neoplasms [40]. The expression of CD30 was also associated
with pregnancy. Kusanovic [42] found that the content
of maternal serum soluble CD30 increased in normal
pregnancy, however, it decreased in preeclampsia and it is8 Journal of Biomedicine and Biotechnology
small for gestational age pregnancies. At the same time,
Lambropoulou et al. [43] proved that during the second
trimester, CD30 was expressed highly in many medullary
thymic epithelial cells (TECs) and Hassall’s corpuscles, but
small numbers of CD30+ TECs were showed during the
late ﬁrst trimester. Large number of researches proved that
if CD30 crosslinked with CD30L, activated signal may be
issued. So it promoted the transmission of intracellular
information. Because that information could be positive
or negative signal, consequently,it resulted in cellular
growth was inhibited or cellular apoptosis [44], cellular
hyperplasia or diﬀerentiation, secretion of cytokine, and so
on. Wright et al. [45] further conﬁrmed that in ALCL cells,
the stimulation of CD30 elicits p21 (waf1)-mediated arrest
through the canonical but not the alternative NF-kappaB
pathway. Gerli et al. [46] reported that there were many
CD30+CD4+, CD30+CD8+ cell in joint synovial ﬂuid of
patientwithRA,largeamountofsCD30existedinperipheral
blood and aﬀected joint synovial ﬂuid, especially in active
stage,ithaddirectrelationwiththetitreofRAF.Ithintedthat
there was relationship between CD30 cell, sCD30 cell, and
TH2 reactive disease. In addition, the increase of CD30 cells
and sCD30 cells was detected in acute stage of TH2 reactive
illness, such as SLE, scleroderma, speciﬁcal scytitis. Many
researches showed the amount of sCD30 increased in active
stage of chronical viral hepatitis B and there were striking
diﬀerences compared with normal controls and virus carries,
hinting the activity of TH2 cytokine in active stage of
hepatitis [47, 48]. In Hodgkin’s disease, the level of serum
sCD30 abnormally increased in active stage in nontreated
patients. The extent of increase related to the stage of illness
andgeneralsymptoms.Itcouldbeanindependentprognosis
index, the higher of sCD30, the worser of prognosis [49].
In ALCL, the great increase of serum sCD30 was observed
as well. In our research, sCD30 was detected in composite
plasmas after the formation of lung cancer. There was not
sCD30 in normal controls, indicating that the amount of
sCD30 went up indeed in forming lung cancer, so far, the
mechanism of increase is not clear. Hargreaves et al. [50]
guessed that it was possible that the function of sCD30
brought into full play by blocking the cross-link of CD30 and
CD30L.
Recently, researches in lung cancer demonstrated that a
series of complicated molecular events involved in carcino-
genesis, such as activation of oncogene and inactivation of
antioncogene. Proteins are the executants of gene function
indeed. Proteomics aim at the large-scale analysis of protein
in tissues, cell, and plasmas, including protein expression,
posttranslational modiﬁcation, and interaction of proteins.
Proteomics has become a hot spot in lung cancer research.
Byapplyingtheproteomicstechnology,manyresearchers
had found a large number of proteins as the candi-
date tumor markers from blood plasmas in lung cancers.
By comparing protein expression levels among 93 lung
adenocarcinomas and 10 uninvolved lung samples, Chen
et al. [51] found that nine diﬀerent enzyme proteins were
identiﬁed by the method of 2D-PAGE and MALDI-MS or
peptide sequencing. All of them increased obviously in the
lung adenocarcinomas, including the antioxidant enzyme
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Figure 9: Mascot search results of protein spot 11 are Transthyretin
(TTR). Mowse Score is 110 (>58, P<. 05).
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Figure 10: Peptide mass ﬁngerprinting map of protein spot 5.
AOE372, ATP5D, B4GALT, cytosolic inorganic pyrophos-
phatase (PPase), GRP58, GSTM4, P4HB, TPI, and ubiquitin
hiolesterase. Brichory et al. [52] identify proteins that
commonly induce an antibody response in lung cancer by
making use of proteomic approach; protein gene product
9.5 (PGP 9.5) was detected in serum. When they took
advantage of A549 lung adenocarcinoma cell line, they haveJournal of Biomedicine and Biotechnology 9
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Figure 11: Mascot search results of protein spot 5 are TNFRS8.
Mowse Score is 110 (>58, P<. 05).
proved that PGP 9.5 existed at the cell surface as well as
secreted. Therefore, the discovery of PGP 9.5 antigen and/or
antibodies in serum of patients with lung cancer showed
that PGP 9.5 may be used in lung cancer screening and
diagnosis.ChatterjiandBorlak[53]foundthateightproteins
were also identiﬁed in serum though they were identiﬁed in
tissue of lung tumor bearing mice. A total of 50 proteins
were identiﬁed in serum, some of which were speciﬁcally
regulated or exclusively expressed either in tumor bearing
or wild-type mice. What is more, they revealed that alpha-
1-antitrypsin (A1AT) and alpha-2-macroglobulin (A2MG)
were upregulated in the serum proteome of 12 months old
mice. In cancer tissue, A1AT was increased in 1-month-
old mice as well. However, the expression of A2MG was
decreased in 1-month-old mice. Hemoglobin subunit alpha
went up in serum samples of lung tumor bearing mice
(12 months). They found MUPs to be upregulated in early
and late stages of tumor development. So MUPs maybe
serve as a biomarker for the diagnosis of lung cancer. They
discovered the expression of transthyretin to be gone up in
1 month and repressed in 12 months old tumor bearing
mice. Thus they suggested that their in-depth validation
could become biomarker candidates for the identiﬁcation
of lung adenocarcinomas. Serological proteome analysis
(SERPA) of ten hLSC tissues was performed by Li et al.
[54] to identify the tumor-associated antigens. The results
showed 36 ± 8d i ﬀerential proteins reactive with patients’
autologous serum, 14 proteins of them were identiﬁed.
In addition, six of the 14 proteins, alpha enolase, pre-B
cell-enhancing factor precursor, triosephosphate isomerase,
phosphoglycerate mutase 1, fructose-bisphosphate aldolase
A, and guanine nucleotide-binding protein beta subunitlike
protein were also increased in hLSCs in the comparative
proteomic research, therefore, it indicated that these 6
hLSC-associated antigens can be applied in diagnosis and
therapy of hLSC. Autoantibodies against triosephosphate
isomerase (Tim) and superoxide dismutase [Mn] (MnSOD)
were detected by Yang et al. [55] in serum from over 20%
patients with LSC but none from the normal controls. Their
results suggested that autoantibody and antigen of Tim and
MnSOD may also be potential application for screening and
diagnosisofthelungsquamouscarcinoma.Atthesametime,
Lisa et al. [56] found that ﬁve truncation forms of serum
amyloid A protein precursor and serum amyloid A1 isoform
2 as a part of the components of the serum proteomic
biomarkers of lung cancer. Diﬀerential expression of some
of them correlated to the diagnosis of lung adenocarcinoma.
These results indicated that it was possible that the serum
proteomic signature of lung cancer was the part of the result
of speciﬁc proteolytic activity in the serum and/or in lung
t u m o r s .L u oe ta l .[ 57] built up the protein conﬁguration in
theplasmasoflungadenocarcinomausingthemethodofthe
SELDI-TOF-MS technology and discovered 5 special protein
peaks which highly expressed in lung adenocarcinoma. In
addition, Liao et al. [58] captured serum proteins in lung
adenocarcinoma by the technology of WCX2 chip and found
10 diﬀerent expressed proteins in which 6 overexpressed
proteins and 4 underexpressed proteins. However, a large
number of lung cancers and normal people were essential
to prove these diﬀerently expressed proteins and special
expressed spectral patterns, to identify and show their
functions in the formation of tumor.
Due to direct examination of the molecular machinery
of cell physiology, including protein expression, sequence
variations and isoforms, posttranslational modiﬁcation, and
protein-protein complexes, proteomics has the self-evident
advantages over genomic-based assays. Nonetheless, there
are certain disadvantages as well, for instance, (i) sample col-
lection,preparation,andanalysisneedrigorousrequirement,
(ii) there are no ampliﬁcation procedures which similar to
PCR that could enable assay to improve making use of
the limited biological starting material, (iii) we are short
of puriﬁcation strategies which could enrich samples for
intended work (e.g., phosphoprotein analysis), and (iv) nec-
essary costs are insuﬃcient for staﬃng and equipping shared
resources or clinical laboratory which can be able to perform
the required assays [59]. Though there are some limitations
in the technology of proteomics, with the maturation of pro-
teomic technique and improvement of sample pretreatment
andpreparationtechnique.Webelieveitsapplicationinanal-
ysis of blood plasmas will become more and more popular
and become a new method for clinical diagnosis and illness
monitoring. In addition, the screening and identiﬁcation of
tumor markers will step into a new stage. In a word, the10 Journal of Biomedicine and Biotechnology
research tactics in proteomics of tumor markers will bring
about far-reaching extensive eﬀects for lung cancer diagnosis
and treatment. It will quicken the process of researches in
lung cancer as well as making a great contribution to win a
victory in human being’s ﬂight with tumor.
6. Conclusion
In our experiment, we made the rat plasmas derived from
lung cancers and the normal controls to be our targets of
observation and comparison. By regulating and optimizing
all conditions of 2DE technique, we ﬁnally obtained satis-
factory 2DE patterns in which the 700 serum proteins were
detected from the lung cancers and the normal controls. In
addition, the 141 diﬀerently expressed protein spots were
acquired by image screen and image analysis. The 82 spots
were overexpressed in lung cancer and the 59 spots were
overexpressed in normal controls. At the same time, we
successfully identiﬁed three proteins including HP, TTR, and
TNFRS8 by making use of the MALDI-TOF-MS to analyze
the 13 diﬀerently expressed protein spots. The increase of
HP, which belongs to APP, hinted the appearance of stress
reaction in the process of forming lung cancer. In addition,
the decrease of TTR, which shows the nutritional state,
hinted the changes of nutritional state. As a member of
tumor necrosis factor super family, TNFRS8 could regulate
the function of immunity and hinted a series of changes
of immunity state in the process of forming lung cancer.
In a conclusion, (i) the plasmas proteins were separated
successfully for proteome research of lung cancer by the
optimized 2DE technique. (ii) There were the diﬀerently
expressed proteins between the normal plasmas and the lung
cancer plasmas. (iii) The diﬀerentially expressed proteins in
plasmas of rat lung cancer provided the evidence for keeping
searching the markers for lung cancer diagnosis and therapy.
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